BioMarin to Participate in Upcoming Investor Conferences

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its participation in three major healthcare investor conferences in September 2025:

• Cantor Global Healthcare Conference on September 3 at 8:00 AM EST
• Wells Fargo Healthcare Conference on September 4 at 8:45 AM EST
• Morgan Stanley Global Healthcare Conference on September 9 at 11:30 AM EST

The company will provide live audio webcasts of the presentations through their investor relations website, with archived versions available for limited time after each event.

Argus Aug 27 session

+2.11% close to close Open Argus

Details

News Market Reaction – BMRN

On Aug 27, the day this news came out, BMRN closed 2.11% above the previous close.

Data tracked by StockTitan Argus for the Aug 27 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Cantor Global Healthcare Conference, September 3 at 8:00 am EST
• Wells Fargo Healthcare Conference, September 4 at 8:45 am EST
• Morgan Stanley Global Healthcare Conference, September 9 at 11:30 am EST

SAN RAFAEL, Calif., Aug. 27, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at upcoming investor conferences in September.

An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com.  

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-investor-conferences-302539513.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is BioMarin (BMRN) presenting at the Morgan Stanley Healthcare Conference 2025?

BioMarin will present at the Morgan Stanley Global Healthcare Conference on September 9, 2025 at 11:30 AM EST.

How can investors access BioMarin's (BMRN) September 2025 conference presentations?

Investors can access live audio webcasts of the presentations at investors.biomarin.com. Archived versions will be available on the website for a limited time after each conference.

Which investor conferences is BioMarin (BMRN) attending in September 2025?

BioMarin is attending three conferences: Cantor Global Healthcare Conference (Sept 3), Wells Fargo Healthcare Conference (Sept 4), and Morgan Stanley Global Healthcare Conference (Sept 9).

What time is BioMarin's (BMRN) presentation at the Cantor Global Healthcare Conference?

BioMarin will present at the Cantor Global Healthcare Conference on September 3, 2025 at 8:00 AM EST.